![Stephanie Vigue](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storia della carriera di Stephanie Vigue
Precedenti posizioni note di Stephanie Vigue
Società | Posizione | Inizio | Fine |
---|---|---|---|
The Fi Co. | Comptroller/Controller/Auditor | 01/03/2020 | 01/09/2021 |
SPECTRUM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/05/2014 | 01/09/2017 |
CARISMA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 17/01/2022 | - |
Formazione di Stephanie Vigue
Husson University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Sesen Bio, Inc.
![]() Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
The Fi Co. |
- Borsa valori
- Insiders
- Stephanie Vigue
- Esperienza